DrugCard is an AI-powered tool designed for local literature screening in the pharmaceutical sector. It enhances drug safety routines and ensures compliance with regulatory standards through continuous and regular monitoring of relevant literature in local markets. This tool provides transparency and traceability, allowing users to accurately track their screening processes, ensuring that they are both complete and holistic. Additionally, DrugCard is scalable, making it an ideal choice for companies aiming to expand their operations across different regions.

Supporting over 100 languages and covering medical journals from more than 35 countries, DrugCard offers extensive screening capabilities. It caters to various users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers, enhancing their project management and screening efficiency. With no heavy capital investment required, DrugCard presents a cost-effective solution for pharmaceutical companies looking to optimize their literature screening processes.